Perahealth
1 known investors
PeraHealth offers the Rothman Index, an FDA-cleared AI predictive analytics system that extracts and analyzes clinical measurements from the EMR to detect patient deterioration early and produce an aggregated score of a patient's physiological condition. It is used by clinicians in hospitals—including medical/surgical, intermediate, and intensive care units, with a pediatric variant—to guide care escalation, safe downgrades, and discharge readiness decisions.
Investors · 1
Frequently asked questions
- What does Perahealth do?
- PeraHealth offers the Rothman Index, an FDA-cleared AI predictive analytics system that extracts and analyzes clinical measurements from the EMR to detect patient deterioration early and produce an aggregated score of a patient's physiological condition. It is used by clinicians in hospitals—including medical/surgical, intermediate, and intensive care units, with a pediatric variant—to guide care escalation, safe downgrades, and discharge readiness decisions.
- Who are Perahealth's investors?
- Perahealth's investors include Keiretsu Forum.